发明名称 |
Tetragalnac containing conjugates and methods for delivery of oligonucleotides |
摘要 |
Disclosed herein is a modular composition comprising 1) an oligonucleotide; 2) one or more tetraGalNAc ligands of Formula (I), which may be the same or different; optionally, 3) one or more linkers, which may be the same or different; and optionally, 4) one or more targeting ligands, solubilizing agents, pharmacokinetics enhancing agents, lipids, and/or masking agents. |
申请公布号 |
US9540639(B2) |
申请公布日期 |
2017.01.10 |
申请号 |
US201314398317 |
申请日期 |
2013.05.01 |
申请人 |
Sirna Therapeutics, Inc. |
发明人 |
Tellers David;Colletti Steven;Dudkin Vadim;Ikemoto Norihiro;Liao Hongbiao;Parish Craig;Pei Tao;Shaw Anthony;Truong Quang;Wang Lijun;Yuan Yu;Zhu Man |
分类号 |
C12N15/113;A61K47/48;C07H15/26 |
主分类号 |
C12N15/113 |
代理机构 |
LeClairRyan |
代理人 |
Townes Jeffrey N.;LeClairRyan |
主权项 |
1. A modular composition comprising
1) a single stranded or double stranded oligonucleotide; 2) one or more tetraGalNAc ligands of Formula (I), (II) or (III), which may be the same or different: optionally, 3) one or more linkers, which may be the same or different; and optionally, 4) one or more targeting ligands, solubilizing agents, pharmacokinetics enhancing agents, lipids, and/or masking agents, wherein X is —O—, —S—, —CR1R2—or —NR1—, wherein R1 and R2 are each independently selected from the group consisting of hydrogen and C1-C6 alkyl; n is 1 , 2, 3, or 4; and the bond with “” indicates the point of attachment of the tetraGalNAc ligands to the oligonucleotide, either directly or through one or more optionally present linkers. |
地址 |
Cambridge MA US |